Tofacitinib, vedolizumab and ustekinumab in patients with ulcerative colitis

被引：1
|
作者：
Chang, Hui-Chin [1 ,2 ,3 ]
Gau, Shuo-Yan [3 ,4 ]
机构：
[1] Chung Shan Med Univ Hosp, Taichung, Taiwan
[2] Chung Shan Med Univ Hosp, Evidence Based Med Ctr, Taichung, Taiwan
[3] Chung Shan Med Univ, Sch Med, 110 Sec 1, Jianguo N Rd, Taichung 40201, Taiwan
[4] Chi Mei Med Ctr, Inst Med Educ, Tainan, Taiwan
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 58卷 / 11-12期
关键词：
D O I：
10.1111/apt.17697
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to Kochhar et al papers. To view these articles, visit and
引用
收藏
页码：1242 / 1242
页数：1
相关论文
共 50 条
  • [1] VEDOLIZUMAB, USTEKINUMAB AND TOFACITINIB AS TRIPLE THERAPY FOR ULCERATIVE COLITIS
    Thurston, Theresa
    Moskow, Joshua
    Glassner, Kerri
    Abraham, Bincy
    GASTROENTEROLOGY, 2023, 164 (04) : S104 - S104
  • [2] VEDOLIZUMAB, USTEKINUMAB AND TOFACITINIB AS TRIPLE THERAPY FOR ULCERATIVE COLITIS
    Thurston, Theresa
    Moskow, Joshua
    Glassner, Kerri
    Abraham, Bincy
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S81 - S81
  • [3] Tofacitinib, vedolizumab and ustekinumab in patients with ulcerative colitis-Authors' reply
    Desai, Aakash
    Regueiro, Miguel
    Kochhar, Gursimran S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1243 - 1243
  • [4] A patient with ulcerative colitis treated with a combination of vedolizumab and tofacitinib
    Bonastre, Pilar Taberner
    Vicente, Gisela Torres
    Cano-Marron, Manuel
    Abizanda, Eva Sese
    Volta Pardo, Tania Dalila
    Schoenenberger-Arnaiz, Joan Antoni
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (06) : 353 - 355
  • [5] Comparison of Colectomy Rates in Biologic Naive Ulcerative Colitis Patients on Ustekinumab and Vedolizumab
    Mohammed, Abdul
    Alchirazi, Khaled Alsabbagh
    Eltelbany, Ahmed
    Hamid, Osama
    Gonzaga, Ernesto Robalino
    Garg, Rajat
    Paranji, Neethi
    Singh, Amandeep
    Kais, Susan
    Regueiro, Miguel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S755 - S756
  • [6] Use of Tofacitinib for the Treatment of Arthritis Associated With Vedolizumab in Ulcerative Colitis
    Rubin, David T.
    Cleveland, Noa Krugliak
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1098 - S1099
  • [7] Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy
    Le Berre, Catherine
    Loeuille, Damien
    Peyrin-Biroulet, Laurent
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (04) : 794 - 796
  • [8] Treatment of Ulcerative Colitis and Seronegative Inflammatory Spondyloarthritis With Vedolizumab and Tofacitinib
    Lee, Joy A.
    Magavi, Pooja R.
    Konijeti, Gauree G.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (11) : E146 - E146
  • [9] Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis
    Lu, Xiaoyan
    Zhou, Zheng-Yi
    Xin, Yiqiao
    Wang, Min-Jung
    Gray, Emma
    Jairath, Vipul
    Lindsay, James Oliver
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (01) : 64 - 77
  • [10] Dual therapy with vedolizumab and tofacitinib in refractory ulcerative colitis patients - single centre experience
    Kolar, M.
    Kastylova, K.
    Lukas, M.
    Duricova, D.
    Hruba, V.
    Machkova, N.
    Cerna, K.
    Jirsa, J.
    Kubickova, K.
    Vojtechova, G.
    Lukas, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 538 - 538
12345